Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2023

Jan 31, 2023

29809_dirs_2023-01-30_feac73aa-48ea-4afc-b7b2-b7f1e7ed6011.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-01-27

Reporting Person: DeSantis Robert (EVP & Chief Product Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-27 Common Stock M 813 $179.7 Acquired 7582 Direct
2023-01-27 Common Stock S 813 $250.0 Disposed 6769 Direct
2023-01-27 Common Stock M 816 $177.9867 Acquired 7585 Direct
2023-01-27 Common Stock S 816 $250.0 Disposed 6769 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-27 Non-Qualified Stock Option (right to buy) $177.9867 M 816 Disposed 2030-02-28 Common Stock (816) Direct
2023-01-27 Non-Qualified Stock Option (right to buy) $179.7 M 813 Disposed 2030-05-11 Common Stock (813) Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.